ExlService Holdings announced that it has been granted ten new U.S. patents covering AI‑driven data and workflow technologies that serve insurance, healthcare, retail, utilities, and financial services.
The patents, granted between March 25 2025 and January 27 2026, enhance the company’s flagship platforms—EXLdata.ai, which automates data modernization and governance, and EXLerate.ai, which orchestrates agentic AI workflows. They also protect domain‑specific large language models such as the EXL Insurance LLM, launched in September 2024 and reported to deliver 20‑30% higher accuracy in claims and underwriting tasks than general‑purpose models.
Data and AI revenue now accounts for roughly 54% of ExlService’s total revenue, up from 53% in FY 2024, and the company reported full‑year 2024 revenue of $1.84 billion, a 12.7% year‑over‑year increase. The new patents reinforce the IP portfolio that underpins this high‑margin, AI‑embedded service offering and support continued growth in data‑centric segments.
Anand Logani, EVP and Chief Data and AI Officer, said the patents underscore ExlService’s commitment to innovation and to building differentiated AI capabilities that deliver measurable outcomes for clients. CEO Rohit Kapoor highlighted the company’s focus on generative AI opportunities in the insurance sector and its partnership with NVIDIA to accelerate LLM development.
Analysts noted the patents as a long‑term value driver, but the announcement did not immediately translate into a positive market reaction, suggesting broader market pressures. The patents strengthen ExlService’s competitive position, enable higher‑margin AI‑embedded services, and signal continued investment in specialized LLMs and AI platform monetization.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.